Vitiligo clinical trials at UC Irvine
3 in progress, 1 open to eligible people
Showing trials for
Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
open to eligible people ages 18 years and up
This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.
Irvine, California and other locations
AMG 714 for Vitiligo
Sorry, in progress, not accepting new patients
This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.
Irvine, California and other locations
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
Sorry, in progress, not accepting new patients
To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
Irvine, California and other locations
Last updated: